Reuters logo
BRIEF-Diplomat provides 2016 financial guidance update
January 9, 2017 / 11:58 AM / a year ago

BRIEF-Diplomat provides 2016 financial guidance update

Jan 9 (Reuters) - Diplomat Pharmacy Inc

* Diplomat provides 2016 financial guidance update

* Now expects 2016 revenue and adjusted EBITDA will be at or near low end of previously announced ranges

* Expect 2017 to be a slower growth year

* Signed a definitive agreement to acquire affinity biotech

* Diplomat will purchase affinity biotech for $16 million cash, and up to an additional $4 million in contingent consideration

* FY2016 earnings per share view $0.85, revenue view $4.51 billion -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below